This is a Validated Antibody Database (VAD) review about bovine VIM, based on 158 published articles (read how Labome selects the articles), using VIM antibody in all methods. It is aimed to help Labome visitors find the most suited VIM antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
MilliporeSigma
mouse monoclonal (V9)
  • western blot knockout validation; human; 1:100; loading ...; fig 4a
  • immunoprecipitation; human; loading ...; fig 1a
  • immunocytochemistry; human; 1:100; loading ...; fig 1b
MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot knockout validation on human samples at 1:100 (fig 4a), in immunoprecipitation on human samples (fig 1a) and in immunocytochemistry on human samples at 1:100 (fig 1b). Biochem Biophys Res Commun (2018) ncbi
MilliporeSigma
mouse monoclonal (V9)
  • western blot knockout validation; human; loading ...; fig 1f
MilliporeSigma VIM antibody (Sigma, V9) was used in western blot knockout validation on human samples (fig 1f). Genes Cells (2017) ncbi
Abcam
mouse monoclonal (RV202)
  • immunocytochemistry; mouse; loading ...; fig 2b
Abcam VIM antibody (AbcamProteintech, ab8978) was used in immunocytochemistry on mouse samples (fig 2b). Oxid Med Cell Longev (2021) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry; mouse; fig 7a
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry on mouse samples (fig 7a). J Inflamm Res (2021) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry; mouse; loading ...; fig 3e
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry on mouse samples (fig 3e). Aging (Albany NY) (2021) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry; human; fig 4j
  • western blot; human; loading ...; fig 4c, 4h
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry on human samples (fig 4j) and in western blot on human samples (fig 4c, 4h). Theranostics (2021) ncbi
mouse monoclonal (RV202)
  • western blot; human; loading ...; fig 3c, 3d
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 3c, 3d). Aging (Albany NY) (2021) ncbi
mouse monoclonal (RV202)
  • western blot; mouse; loading ...; fig 4a
Abcam VIM antibody (Abcam, ab8978) was used in western blot on mouse samples (fig 4a). Nat Commun (2021) ncbi
mouse monoclonal (RV202)
  • western blot; human; loading ...; fig 1a
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 1a). Cancers (Basel) (2021) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; loading ...; fig 2b
Abcam VIM antibody (abcam, ab8978) was used in western blot on human samples at 1:1000 (fig 2b). Cell Death Dis (2021) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; mouse; 1:200; loading ...; fig 4d
Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry on mouse samples at 1:200 (fig 4d). elife (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5e
Abcam VIM antibody (Abcam, ab45939) was used in western blot on human samples at 1:1000 (fig 5e). Mol Cancer (2020) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; rat; 1:1000; loading ...; fig s1b
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on rat samples at 1:1000 (fig s1b). J Neuroinflammation (2020) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 4, 5
Abcam VIM antibody (Abcam, V9) was used in immunocytochemistry on human samples (fig 4, 5). Breast Cancer Res (2019) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - frozen section; mouse; loading ...; fig 1e
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - frozen section on mouse samples (fig 1e). PLoS ONE (2019) ncbi
mouse monoclonal (RV202)
  • western blot; human; loading ...; fig 3a, 3c
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 3a, 3c). Breast Cancer (2019) ncbi
mouse monoclonal (RV202)
  • western blot; human; loading ...; fig 2c
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 2c). FEBS Open Bio (2019) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:3000; fig 2b
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:3000 (fig 2b). Mol Med Rep (2019) ncbi
mouse monoclonal (RV202)
  • western blot; bovine; 70 ng/ml; loading ...; fig 6b
Abcam VIM antibody (Abcam, ab8978) was used in western blot on bovine samples at 70 ng/ml (fig 6b). Graefes Arch Clin Exp Ophthalmol (2019) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:500; loading ...; fig s4i
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:500 (fig s4i). Science (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:5000; loading ...; fig 1a
Abcam VIM antibody (abcam, ab45939) was used in western blot on human samples at 1:5000 (fig 1a). Nat Commun (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:200; loading ...; fig 11c
Abcam VIM antibody (Abcam, ab45939) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 11c). J Clin Invest (2018) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - frozen section; black ferret; loading ...
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - frozen section on black ferret samples . Nature (2018) ncbi
mouse monoclonal (RV202)
  • western blot; human; loading ...; fig 3c
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 3c). J Exp Clin Cancer Res (2018) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; loading ...; fig 2b
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:1000 (fig 2b). Mol Med Rep (2017) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry; human; loading ...; fig 6i
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry on human samples (fig 6i). J Biol Chem (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:10,000; fig 9d
  • western blot; human; 1:1000; loading ...; fig 3a
Abcam VIM antibody (Abcam, ab45939) was used in immunohistochemistry - paraffin section on human samples at 1:10,000 (fig 9d) and in western blot on human samples at 1:1000 (fig 3a). Oncotarget (2017) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; mouse; 1:50; loading ...; fig 1f
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on mouse samples at 1:50 (fig 1f). Am J Transl Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:250; loading ...; fig 1e
Abcam VIM antibody (Abcam, ab45939) was used in western blot on human samples at 1:250 (fig 1e). Int J Mol Med (2017) ncbi
mouse monoclonal (RV202)
  • western blot; human; loading ...; fig 1h
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 1h). Biochem Biophys Res Commun (2016) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; loading ...; fig s2a
In order to elucidate how CELF1 governs the epithelial-to-mesenchymal transition, Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:1000 (fig s2a). Nat Commun (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 2a
In order to test if metastasis can be reduced by targeting cancer-associated fibroblasts with Pirfenidone, Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200; fig 5
  • western blot; mouse; fig 1
Abcam VIM antibody (Abcam, ab45939) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5) and in western blot on mouse samples (fig 1). Mol Vis (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; fig 2C
  • western blot; mouse; fig 2D
Abcam VIM antibody (Abcam, ab45939) was used in immunocytochemistry on mouse samples (fig 2C) and in western blot on mouse samples (fig 2D). Stem Cell Res Ther (2016) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry; human; fig 3A
In order to study the human corneal endothelial cell via a 3D map, Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry on human samples (fig 3A). Sci Rep (2016) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - paraffin section; rat; 1:50; fig 2
  • western blot; rat; 1:1000; fig 2
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - paraffin section on rat samples at 1:50 (fig 2) and in western blot on rat samples at 1:1000 (fig 2). Physiol Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; domestic rabbit; 1:200; fig 5
Abcam VIM antibody (Abcam, ab45939) was used in western blot on domestic rabbit samples at 1:200 (fig 5). Oncol Lett (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; rat; 1:500; fig 1
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on rat samples at 1:500 (fig 1). Mol Med Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; domestic sheep; fig s1
Abcam VIM antibody (Abcam, ab45939) was used in immunocytochemistry on domestic sheep samples (fig s1). Stem Cell Reports (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig 4e
  • western blot; human; loading ...; fig 4c
In order to elucidate how E-cadherin, tight junctions, and the epithelial-to-mesenchymal transition regulates hepatitis C virus entry, Abcam VIM antibody (Abcam, ab45939) was used in immunohistochemistry on human samples (fig 4e) and in western blot on human samples (fig 4c). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; rat; 1:500; fig 5
  • western blot; rat; fig s5
In order to elucidate an increase of apoptosis and disruption of cytoskeleton organization of rat neural crest stem cells via upregulating CXCR4 expression and RhoA-ROCK1-p38 MAPK-p53 signaling due to simulated microgravity, Abcam VIM antibody (Abcam, RV202) was used in immunocytochemistry on rat samples at 1:500 (fig 5) and in western blot on rat samples (fig s5). Stem Cells Dev (2016) ncbi
mouse monoclonal (RV202)
  • western blot; domestic water buffalo; 1:3000; fig 5
Abcam VIM antibody (Abcam, ab8978) was used in western blot on domestic water buffalo samples at 1:3000 (fig 5). Int J Mol Sci (2016) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - paraffin section; rat; loading ...; fig 5c
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - paraffin section on rat samples (fig 5c). Oncotarget (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 5 ug/ml; fig 4
Abcam VIM antibody (abcam, ab8069) was used in immunohistochemistry on rat samples at 5 ug/ml (fig 4). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse; 1:100; fig 13
Abcam VIM antibody (abcam, ab45939) was used in immunocytochemistry on mouse samples at 1:100 (fig 13). J Immunol Res (2016) ncbi
mouse monoclonal (V9)
  • immunoprecipitation; human; fig 4
  • western blot; human; 1:10,000; fig 4
Abcam VIM antibody (Abcam, ab8069) was used in immunoprecipitation on human samples (fig 4) and in western blot on human samples at 1:10,000 (fig 4). Nat Commun (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; loading ...; fig 4b
  • western blot; human; loading ...; fig 4a
  • immunocytochemistry; mouse; loading ...; fig 4g
  • western blot; mouse; loading ...; fig 4f
Abcam VIM antibody (Abcam, Ab8978) was used in immunocytochemistry on human samples (fig 4b), in western blot on human samples (fig 4a), in immunocytochemistry on mouse samples (fig 4g) and in western blot on mouse samples (fig 4f). Nat Commun (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 2b
  • western blot; human; loading ...; fig 2c
In order to explore the link between HDAC1 and progesterone receptor A in myometrium samples, Abcam VIM antibody (Abcam, ab8069) was used in immunocytochemistry on human samples (fig 2b) and in western blot on human samples (fig 2c). Reprod Sci (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; fig 2
Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry on human samples (fig 2). Int Braz J Urol (2015) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:500; fig 2
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:500 (fig 2). Mol Med Rep (2016) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; loading ...; fig 5C
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:1000 (fig 5C). Mol Oncol (2016) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 1c
Abcam VIM antibody (Abcam, Ab8978) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1c). PLoS ONE (2015) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:2500
In order to describe a novel type of kidney cell, Abcam VIM antibody (Abcam, ab-45939) was used in immunohistochemistry on mouse samples at 1:2500. Cell Tissue Res (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:200
In order to study the insulin/IGF1 signaling pathway in human astrocytes, Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:200. Mol Brain (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 3
Abcam VIM antibody (Abcam, ab8069) was used in immunocytochemistry on human samples (fig 3). Mol Cell Proteomics (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:25
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:25. Biomaterials (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:20; fig 4
In order to discuss methods to generate and study neural crest cells, Abcam VIM antibody (Abcam, Ab8978) was used in immunocytochemistry on human samples at 1:20 (fig 4). Cell J (2015) ncbi
mouse monoclonal (RV202)
  • western blot; human; 1:1000; fig 2
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples at 1:1000 (fig 2). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 2e
Abcam VIM antibody (Abcam, ab8069) was used in western blot on human samples (fig 2e). PLoS ONE (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:100; loading ...; fig 4d
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:100 (fig 4d). Mol Med Rep (2015) ncbi
mouse monoclonal (RV202)
  • western blot; human; fig 3
Abcam VIM antibody (Abcam, AB8978) was used in western blot on human samples (fig 3). Sci Rep (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human
In order to report a protocol using a non-integrating Sendai virus vector for transduction of Yamanaka factors into urine cells collected from patients with muscular dystrophy, Abcam VIM antibody (Abcam, ab8978-100) was used in immunocytochemistry on human samples . J Vis Exp (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
Abcam VIM antibody (Abcam, ab8069) was used in immunocytochemistry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; fig 1
Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry - paraffin section on human samples (fig 1). In Vitro Cell Dev Biol Anim (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; rat
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on rat samples . Int J Mol Med (2014) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:200
Abcam VIM antibody (Abcam, ab8978) was used in immunocytochemistry on human samples at 1:200. Acta Naturae (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:100; fig 7
In order to explore interactions between human tumor cells and a humanized bone microenvironment, Abcam VIM antibody (Abcam, ab8069) was used in immunohistochemistry on human samples at 1:100 (fig 7). Clin Exp Metastasis (2014) ncbi
mouse monoclonal (RV202)
  • western blot; human; fig 2A
Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples (fig 2A). Prostate (2014) ncbi
mouse monoclonal (RV202)
  • immunohistochemistry - paraffin section; mouse
Abcam VIM antibody (Abcam, ab8978) was used in immunohistochemistry - paraffin section on mouse samples . Am J Pathol (2013) ncbi
mouse monoclonal (RV202)
  • western blot; human
In order to study the role of p63 in epithelial homeostasis and development, Abcam VIM antibody (Abcam, ab8978) was used in western blot on human samples . PLoS ONE (2013) ncbi
Invitrogen
mouse monoclonal (V9)
  • western blot; human; 1:1000; loading ...
Invitrogen VIM antibody (Thermo Fisher Scientific, MA5-11883) was used in western blot on human samples at 1:1000. elife (2020) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:2000; loading ...; fig 1d
Invitrogen VIM antibody (Thermo Fisher, MS129P) was used in western blot on human samples at 1:2000 (fig 1d). Proc Natl Acad Sci U S A (2020) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 1a
Invitrogen VIM antibody (Thermo Fisher Scientific, MA5-11883) was used in western blot on human samples (fig 1a). Biol Open (2019) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 2c
In order to investigate the effect off miR-509-5p and miR-1243 on gemcitabine efficacy in pancreatic cancer and its mechanism, Invitrogen VIM antibody (Thermo Fisher, V9) was used in western blot on human samples (fig 2c). Sci Rep (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 2
In order to describe the differences between Xp11 translocation renal cell carcinoma and the corresponding mesenchymal neoplasm, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Hum Pathol (2017) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:2000; loading ...; fig 5a
In order to test if Dub3 contributes to Snail1 stability in cancer cells, Invitrogen VIM antibody (Neomarkers, Ab-2) was used in western blot on human samples at 1:2000 (fig 5a). Nat Commun (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; pigs ; loading ...
In order to generate an enzymatic approach to isolate highly purified populations of porcine aortic endothelial and smooth muscle cells, Invitrogen VIM antibody (Thermo Fisher, MA5-11883) was used in immunocytochemistry on pigs samples . J Cell Physiol (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; tbl 2
In order to characterize eight cases of renal cell carcinoma cases with NONO-TFE3, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Mod Pathol (2017) ncbi
chicken polyclonal
  • immunohistochemistry; mouse; loading ...; fig 5c
In order to report that saturated and unsaturated fatty acids are differentially processed in the murine hypothalamus, Invitrogen VIM antibody (Invitrogen, PA1-10003) was used in immunohistochemistry on mouse samples (fig 5c). Glia (2017) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:100
In order to discuss the characteristics of Ewing's Sarcoma family of tumors of urinary bladder, Invitrogen VIM antibody (Thermo Scientific, V9) was used in immunohistochemistry on human samples at 1:100. Balkan Med J (2016) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:200; fig 1
In order to study the role of kif3a in dental mesenchymal stem and precursor cell differentiation, Invitrogen VIM antibody (Thermo Fisher, OMA1-06001) was used in immunocytochemistry on human samples at 1:200 (fig 1). Mol Med Rep (2016) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 1:1000; loading ...; fig 7d
In order to use electroconducting microfibers to synergistically stimulate the proliferation and migration of glial progenitor cells, Invitrogen VIM antibody (Neomarkers, MS-129) was used in immunohistochemistry on rat samples at 1:1000 (fig 7d). Acta Biomater (2016) ncbi
mouse monoclonal (V9)
  • western blot; mouse; fig 2
In order to describe a technique to measure cell mechanotype, Invitrogen VIM antibody (Thermo Scientific, MS-129-PO) was used in western blot on mouse samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200; fig 3
In order to determine the desmoplastic interface in xenograft tumor in mice comprised of stromal and endothelial cells, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 3). Pathol Res Pract (2015) ncbi
mouse monoclonal (RV203)
  • western blot; human; fig 7
In order to study ectosome-mediated trafficking in fibroblasts, Invitrogen VIM antibody (Thermo, RV203) was used in western blot on human samples (fig 7). Biochim Biophys Acta (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000
In order to test if urinary fluid shear stress alters the epithelial characteristics of the renal tubule, Invitrogen VIM antibody (Neomarkers, MS-129-P) was used in western blot on human samples at 1:1000. PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • western blot; human
In order to evaluate the effect of aspirin in mesenchymal to epithelial transition, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in western blot on human samples . Lab Invest (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:150
In order to describe a 40-year-old female patient with ovarian microcystic stromal tumor and familial adenomatous polyposis, Invitrogen VIM antibody (ZYMED, V9) was used in immunohistochemistry - paraffin section on human samples at 1:150. Genes Chromosomes Cancer (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; fig s6
In order to characterize evolutionarily conserved DNA architecture which determines target specificity of the TWIST family bHLH transcription factors, Invitrogen VIM antibody (Thermo Scientific, MS-129-P) was used in western blot on human samples (fig s6). Genes Dev (2015) ncbi
mouse monoclonal (RV202)
  • immunocytochemistry; human; 1:400
In order to study the effects of dental papilla-derived human dental pulp cells on osteogenic differentiation of human dental follicle cells, Invitrogen VIM antibody (Thermo Fisher Scientific, OMA1-06001) was used in immunocytochemistry on human samples at 1:400. J Mol Histol (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; rat; 1:50; fig 7g
In order to characterize a small population of Thy1(+) mesenchymal-epithelial cells present in rat liver., Invitrogen VIM antibody (Lab Vision Corporation, MS129-PO) was used in immunocytochemistry on rat samples at 1:50 (fig 7g). Am J Pathol (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Hum Pathol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:200
Invitrogen VIM antibody (Thermo Fisher Scientific, V9) was used in immunohistochemistry - paraffin section on human samples at 1:200. Rom J Morphol Embryol (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
Invitrogen VIM antibody (Thermo, V9) was used in immunocytochemistry on human samples . Eur J Cell Biol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:200
In order to determine the role of myofibroblasts in salivary gland adenoid cystic carcinoma invasiveness, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry on human samples at 1:200. Histopathology (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
In order to isolate and characterize PDGFR-beta(+) perivascular cells from infantile hemangioma, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in immunocytochemistry on human samples . Int J Clin Exp Pathol (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human
  • immunocytochemistry; human
  • western blot; human; 1:1000
Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples , in immunocytochemistry on human samples and in western blot on human samples at 1:1000. Br J Cancer (2014) ncbi
mouse monoclonal (V9)
  • western blot; mouse; fig 3
In order to determine the difference in apparent diffusion coefficient values between epithelial- and mesenchymal-like subcutaneous mouse xenografted tumors using diffusion-weighted magnetic resonance imaging, Invitrogen VIM antibody (Thermo Scientific, MS-129-P0) was used in western blot on mouse samples (fig 3). Int J Mol Sci (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; fig 2
In order to present a case of not otherwise specified-type sarcoma with CD10 expression in the left breast, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry on human samples (fig 2). Diagn Pathol (2013) ncbi
mouse monoclonal (V9)
  • western blot; human
In order to study the role of TWIST1 activation by the MMSET histone methyltransferase in driving epithelial-to-mesenchymal transition and invasiveness in prostate cancer, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in western blot on human samples . Oncogene (2013) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; fig 3
In order to assess the incidence and prognostic significance of the epithelial to mesenchymal transition in cancer of unknown primary, Invitrogen VIM antibody (Invitrogen, V9) was used in immunohistochemistry - paraffin section on human samples (fig 3). Anticancer Res (2012) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
In order to test if MSCs in hemangioma also reside in the perivascular region, Invitrogen VIM antibody (Thermo Scientific, MS-129) was used in immunocytochemistry on human samples . Pediatr Dev Pathol (2012) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 2
In order to characterize feline endometrial adenocarcinomas immunohistochemically, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 2). J Comp Pathol (2009) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; pigs ; fig 7
In order to analyze the contributions of adipose tissue extract on wound healing, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on pigs samples (fig 7). Wound Repair Regen (2007) ncbi
mouse monoclonal (V9)
  • western blot; human; fig 2
  • immunohistochemistry; dogs; fig 2
In order to study Goosecoid in human breast cells, Invitrogen VIM antibody (Neomarkers, MS129P) was used in western blot on human samples (fig 2) and in immunohistochemistry on dogs samples (fig 2). Proc Natl Acad Sci U S A (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:400
In order to perform a prospective study of epithelial-to-mesenchymal transition markers in biopsies obtained after engraftment from patients who received deceased donor kidneys and who had stable renal function, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry on human samples at 1:400. Am J Transplant (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat; tbl 1
In order to characterize the tissue distribution of cytoskeletal proteins, cellular adhesion molecules, and proliferation markers in the follicular wall of letrozole-induced polycystic ovaries, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on rat samples (tbl 1). Arch Med Res (2006) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; rat
In order to compare the follicular structure and hormonal profiles of rats treated with the adrenocorticotrophic hormone with two experimental models of polycystic ovarian syndrome, Invitrogen VIM antibody (Zymed, V9) was used in immunohistochemistry - paraffin section on rat samples . Physiol Res (2007) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human
  • immunohistochemistry; human
In order to report on a case of soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions, Invitrogen VIM antibody (Neomarkers, V9) was used in immunohistochemistry - paraffin section on human samples and in immunohistochemistry on human samples . Pathol Res Pract (2005) ncbi
mouse monoclonal (V9)
  • western blot; human; fig 5
In order to investigate the effect of COX-2 overexpression on inhibiting proliferation, apoptosis and differentiation, Invitrogen VIM antibody (Lab Vision, MS-129-P) was used in western blot on human samples (fig 5). Int J Cancer (2005) ncbi
Novus Biologicals
mouse monoclonal (VM452)
  • immunohistochemistry - paraffin section; chicken; 1:400; loading ...; fig 3b
Novus Biologicals VIM antibody (Novus, VM452) was used in immunohistochemistry - paraffin section on chicken samples at 1:400 (fig 3b). J Vet Med Sci (2020) ncbi
chicken polyclonal (6C5cc)
  • immunohistochemistry - paraffin section; mouse; 1:200; loading ...; fig 2k
In order to propose that Baf60c plays contributes to heart development and regeneration in young mice, Novus Biologicals VIM antibody (Novus Biologicals, NB300-223) was used in immunohistochemistry - paraffin section on mouse samples at 1:200 (fig 2k). Dev Growth Differ (2016) ncbi
EnCor Biotechnology
chicken polyclonal
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s4a
EnCor Biotechnology VIM antibody (Encor Biotechnologies, CPCA-Vim) was used in immunohistochemistry - paraffin section on mouse samples (fig s4a). Cell (2019) ncbi
MilliporeSigma
mouse monoclonal (V9)
  • western blot; human; 1:100; loading ...; fig 5a
MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot on human samples at 1:100 (fig 5a). Nat Commun (2021) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:200; loading ...; fig 4
MilliporeSigma VIM antibody (Sigma-Aldrich, V6630) was used in western blot on human samples at 1:200 (fig 4). NPJ Parkinsons Dis (2020) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; rat; 1:200; loading ...; fig 8
MilliporeSigma VIM antibody (Sigma, V6630) was used in immunohistochemistry on rat samples at 1:200 (fig 8). Int J Mol Sci (2020) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; loading ...; fig 1a
MilliporeSigma VIM antibody (Sigma-Aldrich, v6389) was used in western blot on human samples at 1:1000 (fig 1a). Cell Death Dis (2019) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; black ferret; 1:200; loading ...; fig 11
MilliporeSigma VIM antibody (Sigma, V6389) was used in immunohistochemistry on black ferret samples at 1:200 (fig 11). J Comp Neurol (2019) ncbi
mouse monoclonal (LN-6)
  • immunohistochemistry - frozen section; mouse; 1:500; loading ...; fig 7b
MilliporeSigma VIM antibody (Sigma-Aldrich, V2258) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (fig 7b). Development (2019) ncbi
mouse monoclonal (V9)
  • western blot knockout validation; human; 1:100; loading ...; fig 4a
  • immunoprecipitation; human; loading ...; fig 1a
  • immunocytochemistry; human; 1:100; loading ...; fig 1b
MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot knockout validation on human samples at 1:100 (fig 4a), in immunoprecipitation on human samples (fig 1a) and in immunocytochemistry on human samples at 1:100 (fig 1b). Biochem Biophys Res Commun (2018) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; loading ...; fig 3c
  • western blot; human; loading ...; fig 3d
MilliporeSigma VIM antibody (Sigma-Aldrich, V6389) was used in immunocytochemistry on human samples (fig 3c) and in western blot on human samples (fig 3d). Cell Death Differ (2019) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 2a
MilliporeSigma VIM antibody (Sigma Life Sciences, V6389) was used in western blot on human samples (fig 2a). Oncogene (2018) ncbi
mouse monoclonal (V9)
  • western blot knockout validation; human; loading ...; fig 1f
MilliporeSigma VIM antibody (Sigma, V9) was used in western blot knockout validation on human samples (fig 1f). Genes Cells (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; 1:50; loading ...; fig 1b
In order to investigate the stromal extracellular matrix-mediated gene expression and the associated phenotypic response, MilliporeSigma VIM antibody (Sigma, v6389) was used in immunocytochemistry on human samples at 1:50 (fig 1b). Sci Rep (2017) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; 1:100; loading ...; fig s2b
MilliporeSigma VIM antibody (Sigma, V9) was used in immunocytochemistry on human samples at 1:100 (fig s2b). J Cell Sci (2017) ncbi
mouse monoclonal (V9)
  • western blot; human; loading ...; fig 5f
In order to evaluate the effects of matrix stiffness on vessel growth and integrity during angiogenesis, MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot on human samples (fig 5f). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:500; loading ...; fig 1b
MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot on human samples at 1:500 (fig 1b). Cancer Sci (2017) ncbi
mouse monoclonal (LN-6)
  • western blot; human; 1:2000; loading ...; fig 1b
  • immunohistochemistry; mouse; 1:2000; loading ...; fig 3f
MilliporeSigma VIM antibody (Sigma, V2258) was used in western blot on human samples at 1:2000 (fig 1b) and in immunohistochemistry on mouse samples at 1:2000 (fig 3f). Nat Commun (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; African green monkey; loading ...; fig 3a
  • immunocytochemistry; human; loading ...; fig 4
In order to elucidate how cells handle and respond to misfolded Caveolin-1, MilliporeSigma VIM antibody (Sigma, V6389) was used in immunocytochemistry on African green monkey samples (fig 3a) and in immunocytochemistry on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 2
MilliporeSigma VIM antibody (Sigma, V9) was used in western blot on human samples at 1:1000 (fig 2). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; mouse; fig 1
In order to study neural N-glycomics and their epigenetic regulation, MilliporeSigma VIM antibody (Sigma, V9) was used in immunocytochemistry on mouse samples (fig 1). Proteomics (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig 2
  • western blot; human; fig 2
MilliporeSigma VIM antibody (sigma, V6389) was used in immunocytochemistry on human samples (fig 2) and in western blot on human samples (fig 2). J Exp Clin Cancer Res (2016) ncbi
mouse monoclonal (LN-6)
  • immunocytochemistry; mouse; 1:200; fig 1
In order to study cancer-associated fibroblasts and Cdc42EP3 function regulated by Cdc42, MilliporeSigma VIM antibody (Sigma, V2258) was used in immunocytochemistry on mouse samples at 1:200 (fig 1). Small Gtpases (2017) ncbi
mouse monoclonal (V9)
  • western blot; rat; fig 2b
In order to study how glucose and glutamate transporters are regulated by Ghrelin in hypothalamic astrocytes, MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot on rat samples (fig 2b). Sci Rep (2016) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 2
In order to research induction of epithelial-to-mesenchymal transition by Polo-like kinase 1 and promotion of epithelial cell motility by activating CRAF/ERK signaling, MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot on human samples at 1:1000 (fig 2). elife (2016) ncbi
mouse monoclonal (V9)
  • western blot; mouse; 1:100; fig 2
In order to elucidate the favor of Smad-independent TGF-beta signaling that drives EMT in pancreatic ductal adenocarcinoma due to TAp73 loss, MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot on mouse samples at 1:100 (fig 2). Cell Death Differ (2016) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human; fig s1a
  • western blot; human; 1:1000; fig 2d
MilliporeSigma VIM antibody (Sigma Aldrich, V6389) was used in immunocytochemistry on human samples (fig s1a) and in western blot on human samples at 1:1000 (fig 2d). Sci Rep (2016) ncbi
mouse monoclonal (LN-6)
  • western blot; rat; fig 1
In order to test the relationship between epithelial mesenchymal transition induced by transforming growth factor beta 1 is blocked by an antagonist of translation factor eIF4E, MilliporeSigma VIM antibody (Sigma-Aldrich, V2258) was used in western blot on rat samples (fig 1). Sci Rep (2015) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:100; fig 3
MilliporeSigma VIM antibody (Sigma-Aldrich, V6389) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 3). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • western blot; rat; fig 2
MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot on rat samples (fig 2). Sci Rep (2015) ncbi
mouse monoclonal (LN-6)
  • western blot; dogs; fig 1c
In order to discover the mRNA and miRNA involved in epithelial-mesenchymal transition in MDCK cells, MilliporeSigma VIM antibody (Sigma, V2258) was used in western blot on dogs samples (fig 1c). BMC Genomics (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 4
MilliporeSigma VIM antibody (Sigma-Aldrich, V6389) was used in western blot on human samples at 1:1000 (fig 4). PLoS Med (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
MilliporeSigma VIM antibody (Sigma-Aldrich, V9) was used in immunocytochemistry on human samples . PLoS ONE (2015) ncbi
mouse monoclonal (LN-6)
  • immunohistochemistry - paraffin section; human; fig 8
In order to study the increase in stromal collagen and immune cells within the mammary epithelium shown as high mammographic density, MilliporeSigma VIM antibody (Sigma-Aldrich, V2258) was used in immunohistochemistry - paraffin section on human samples (fig 8). Breast Cancer Res (2015) ncbi
mouse monoclonal (LN-6)
  • immunocytochemistry; human; fig s1
  • western blot; human; fig s1
MilliporeSigma VIM antibody (Sigma, V2258) was used in immunocytochemistry on human samples (fig s1) and in western blot on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; dogs; 1:1600
MilliporeSigma VIM antibody (Sigma, V6389) was used in immunocytochemistry on dogs samples at 1:1600. Vet J (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; 1:1000; fig 4
MilliporeSigma VIM antibody (Sigma-Aldrich, V6389) was used in western blot on human samples at 1:1000 (fig 4). Oncol Lett (2015) ncbi
mouse monoclonal (LN-6)
  • western blot; human; 1:500; fig 3d
In order to analyze the accumulation of intermediate filament protein accumulation in motor neurons obtained from giant axonal neuropathy iPSCs and the rescue by restoration of gigaxonin, MilliporeSigma VIM antibody (Sigma, V2258) was used in western blot on human samples at 1:500 (fig 3d). Hum Mol Genet (2015) ncbi
mouse monoclonal (V9)
  • western blot; human; fig 3
In order to discuss drugs that prevent the epithelial-mesenchymal transition, MilliporeSigma VIM antibody (Sigma, V6389) was used in western blot on human samples (fig 3). COPD (2015) ncbi
mouse monoclonal (LN-6)
  • immunocytochemistry; mouse; 1:500
MilliporeSigma VIM antibody (Sigma, V2258) was used in immunocytochemistry on mouse samples at 1:500. Front Genet (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry; human; 1:30
In order to investigate the role of CAR in pluripotency and tight junctions of human embryos and stem cells, MilliporeSigma VIM antibody (Sigma-Aldrich, V6389) was used in immunohistochemistry on human samples at 1:30. Reproduction (2014) ncbi
mouse monoclonal (V9)
  • western blot; human
In order to describe a new in vitro model to test the effect of an aligned fibrous environment on cancer cell morphology and behavior, MilliporeSigma VIM antibody (Sigma Aldrich, V6389) was used in western blot on human samples . Acta Biomater (2014) ncbi
mouse monoclonal (V9)
  • immunohistochemistry - paraffin section; human; 1:20000
MilliporeSigma VIM antibody (Sigma, V9) was used in immunohistochemistry - paraffin section on human samples at 1:20000. Biomed Res Int (2014) ncbi
mouse monoclonal (V9)
  • immunocytochemistry; human
MilliporeSigma VIM antibody (Sigma-Aldrich, V9) was used in immunocytochemistry on human samples . Mol Cell Endocrinol (2014) ncbi
mouse monoclonal (V9)
  • reverse phase protein lysate microarray; human; 1:500
In order to study the epithelial to mesenchymal transition in the bronchial epithelium of patients with COPD and smokers, MilliporeSigma VIM antibody (Sigma, V6389) was used in reverse phase protein lysate microarray on human samples at 1:500. Pulm Pharmacol Ther (2014) ncbi
Developmental Studies Hybridoma Bank
mouse monoclonal (AMF-17b)
  • western blot; human; loading ...; fig s1b
Developmental Studies Hybridoma Bank VIM antibody (DSHB, AMF-17b) was used in western blot on human samples (fig s1b). Adv Sci (Weinh) (2020) ncbi
mouse monoclonal (AMF-17b)
  • western blot; human; 1:500; loading ...; fig s4a
Developmental Studies Hybridoma Bank VIM antibody (DSHB, AMF-17b) was used in western blot on human samples at 1:500 (fig s4a). Sci Rep (2019) ncbi
mouse monoclonal (AMF-17b)
  • western blot; human; loading ...; fig 1b
Developmental Studies Hybridoma Bank VIM antibody (DSHB, AMF-17b) was used in western blot on human samples (fig 1b). Mol Carcinog (2015) ncbi
mouse monoclonal (AMF-17b)
  • immunohistochemistry; pigs ; 1:100
Developmental Studies Hybridoma Bank VIM antibody (Hybridoma bank, AMF-17b) was used in immunohistochemistry on pigs samples at 1:100. PLoS ONE (2012) ncbi
Articles Reviewed
  1. Fang L, Wang W, Chen J, Zuo A, Gao H, Yan T, et al. Osthole Attenuates Bleomycin-Induced Pulmonary Fibrosis by Modulating NADPH Oxidase 4-Derived Oxidative Stress in Mice. Oxid Med Cell Longev. 2021;2021:3309944 pubmed publisher
  2. Cao W, Song S, Fang G, Li Y, Wang Y, Wang Q. Cadherin-11 Deficiency Attenuates Ang-II-Induced Atrial Fibrosis and Susceptibility to Atrial Fibrillation. J Inflamm Res. 2021;14:2897-2911 pubmed publisher
  3. Huang S, Luo W, Wu G, Shen Q, Zhuang Z, Yang D, et al. Inhibition of CDK9 attenuates atherosclerosis by inhibiting inflammation and phenotypic switching of vascular smooth muscle cells. Aging (Albany NY). 2021;13:14892-14909 pubmed publisher
  4. Qin X, Li J, Wang S, Lv J, Luan F, Liu Y, et al. Serotonin/HTR1E signaling blocks chronic stress-promoted progression of ovarian cancer. Theranostics. 2021;11:6950-6965 pubmed publisher
  5. Yao J, Yang Z, Yang J, Wang Z, Zhang Z. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis. Aging (Albany NY). 2021;13:13726-13738 pubmed publisher
  6. Srivastava S, Zhou H, Setia O, Liu B, Kanasaki K, Koya D, et al. Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy. Nat Commun. 2021;12:2368 pubmed publisher
  7. Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
  8. Ganig N, Baenke F, Thepkaysone M, Lin K, Rao V, Wong F, et al. Proteomic Analyses of Fibroblast- and Serum-Derived Exosomes Identify QSOX1 as a Marker for Non-invasive Detection of Colorectal Cancer. Cancers (Basel). 2021;13: pubmed publisher
  9. Wan L, Wang Y, Zhang Z, Wang J, Niu M, Wu Y, et al. Elevated TEFM expression promotes growth and metastasis through activation of ROS/ERK signaling in hepatocellular carcinoma. Cell Death Dis. 2021;12:325 pubmed publisher
  10. Kano M, Takanashi M, Oyama G, Yoritaka A, Hatano T, Shiba Fukushima K, et al. Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations. NPJ Parkinsons Dis. 2020;6:33 pubmed publisher
  11. Li J, Zhang L, Zheng Y, Shao R, Liang Q, Yu W, et al. BAD inactivation exacerbates rheumatoid arthritis pathology by promoting survival of sublining macrophages. elife. 2020;9: pubmed publisher
  12. Hosseini K, Taubenberger A, Werner C, Fischer Friedrich E. EMT-Induced Cell-Mechanical Changes Enhance Mitotic Rounding Strength. Adv Sci (Weinh). 2020;7:2001276 pubmed publisher
  13. Huang Y, Liang C, Ritz D, Coelho R, Septiadi D, Estermann M, et al. Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis. elife. 2020;9: pubmed publisher
  14. Prado N, Muñoz E, Farias Altamirano L, Aguiar F, Ponce Zumino A, Sánchez F, et al. Reperfusion Arrhythmias Increase after Superior Cervical Ganglionectomy Due to Conduction Disorders and Changes in Repolarization. Int J Mol Sci. 2020;21: pubmed publisher
  15. Jin D, Guo J, Wu Y, Yang L, Wang X, Du J, et al. m6A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020;19:40 pubmed publisher
  16. Xiong G, Chen J, Zhang G, Wang S, Kawasaki K, Zhu J, et al. Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction. Proc Natl Acad Sci U S A. 2020;117:3748-3758 pubmed publisher
  17. Hou K, Li G, Zhao J, Xu B, Zhang Y, Yu J, et al. Bone mesenchymal stem cell-derived exosomal microRNA-29b-3p prevents hypoxic-ischemic injury in rat brain by activating the PTEN-mediated Akt signaling pathway. J Neuroinflammation. 2020;17:46 pubmed publisher
  18. Yoshida K, Miyoshi T, Murakami T. Multicystic peritoneal tumor in two layer hens. J Vet Med Sci. 2020;82:294-298 pubmed publisher
  19. Bi J, Yang S, Li L, Dai Q, Borcherding N, Wagner B, et al. Metadherin enhances vulnerability of cancer cells to ferroptosis. Cell Death Dis. 2019;10:682 pubmed publisher
  20. Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer. Breast Cancer Res. 2019;21:98 pubmed publisher
  21. Seki M, Furukawa N, Koitabashi N, Obokata M, Conway S, Arakawa H, et al. Periostin-expressing cell-specific transforming growth factor-β inhibition in pulmonary artery prevents pulmonary arterial hypertension. PLoS ONE. 2019;14:e0220795 pubmed publisher
  22. Vazquez Iglesias L, Barcia Castro L, Rodríguez Quiroga M, Páez de la Cadena M, Rodríguez Berrocal J, Cordero O. Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets. Biol Open. 2019;8: pubmed publisher
  23. Gao X, Liu X, Lu Y, Wang Y, Cao W, Liu X, et al. PIM1 is responsible for IL-6-induced breast cancer cell EMT and stemness via c-myc activation. Breast Cancer. 2019;: pubmed publisher
  24. Gao R, Kanasaki K, Li J, Kitada M, Okazaki T, Koya D. βklotho is essential for the anti-endothelial mesenchymal transition effects of N-acetyl-seryl-aspartyl-lysyl-proline. FEBS Open Bio. 2019;9:1029-1038 pubmed publisher
  25. Vanneste M, Huang Q, Li M, Moose D, Zhao L, STAMNES M, et al. High content screening identifies monensin as an EMT-selective cytotoxic compound. Sci Rep. 2019;9:1200 pubmed publisher
  26. Hutchinson E, Chatterjee M, Reyes L, Djankpa F, Valiant W, Dardzinski B, et al. The effect of Zika virus infection in the ferret. J Comp Neurol. 2019;527:1706-1719 pubmed publisher
  27. Sharon N, Chawla R, Mueller J, Vanderhooft J, Whitehorn L, Rosenthal B, et al. A Peninsular Structure Coordinates Asynchronous Differentiation with Morphogenesis to Generate Pancreatic Islets. Cell. 2019;176:790-804.e13 pubmed publisher
  28. Shinozuka T, Takada R, Yoshida S, Yonemura S, Takada S. Wnt produced by stretched roof-plate cells is required for the promotion of cell proliferation around the central canal of the spinal cord. Development. 2019;146: pubmed publisher
  29. Zhang C, Wang Y. Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway. Mol Med Rep. 2019;19:1203-1209 pubmed publisher
  30. Jiu Y. Vimentin intermediate filaments function as a physical barrier during intracellular trafficking of caveolin-1. Biochem Biophys Res Commun. 2018;507:161-167 pubmed publisher
  31. Deissler H, Lang G, Lang G. Fate of the Fc fusion protein aflibercept in retinal endothelial cells: competition of recycling and degradation. Graefes Arch Clin Exp Ophthalmol. 2019;257:83-94 pubmed publisher
  32. Gut G, Herrmann M, Pelkmans L. Multiplexed protein maps link subcellular organization to cellular states. Science. 2018;361: pubmed publisher
  33. Hsu J, Xia W, Hsu Y, Chan L, Yu W, Cha J, et al. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018;9:1908 pubmed publisher
  34. Zhu Y, Qu C, Hong X, Jia Y, Lin M, Luo Y, et al. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ. 2019;26:306-320 pubmed publisher
  35. Rademaker G, Hennequière V, Brohée L, Nokin M, Lovinfosse P, Durieux F, et al. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene. 2018;37:4398-4412 pubmed publisher
  36. Fu X, Khalil H, Kanisicak O, Boyer J, Vagnozzi R, Maliken B, et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J Clin Invest. 2018;128:2127-2143 pubmed publisher
  37. Johnson M, Sun X, Kodani A, Borges Monroy R, Girskis K, Ryu S, et al. Aspm knockout ferret reveals an evolutionary mechanism governing cerebral cortical size. Nature. 2018;556:370-375 pubmed publisher
  38. Zheng C, Wang J, Lin M, Zhang P, Liu L, Lin J, et al. CDK5RAP3 suppresses Wnt/β-catenin signaling by inhibiting AKT phosphorylation in gastric cancer. J Exp Clin Cancer Res. 2018;37:59 pubmed publisher
  39. You S, Guan Y, Li W. Epithelial?mesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3. Mol Med Rep. 2017;: pubmed publisher
  40. Ise H, Yamasaki S, Sueyoshi K, Miura Y. Elucidation of GlcNAc-binding properties of type III intermediate filament proteins, using GlcNAc-bearing polymers. Genes Cells. 2017;22:900-917 pubmed publisher
  41. Luo W, Tan P, Rodriguez M, He L, Tan K, Zeng L, et al. Leucine-rich repeat-containing G protein-coupled receptor 4 (Lgr4) is necessary for prostate cancer metastasis via epithelial-mesenchymal transition. J Biol Chem. 2017;292:15525-15537 pubmed publisher
  42. Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, et al. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep. 2017;7:4002 pubmed publisher
  43. Lu J, Yang Y, Guo G, Liu Y, Zhang Z, Dong S, et al. IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway. Oncotarget. 2017;8:49502-49514 pubmed publisher
  44. Ji H, Xiong Y, Zhang E, Song W, Gao Z, Yao F, et al. Which has more stem-cell characteristics: Müller cells or Müller cells derived from in vivo culture in neurospheres?. Am J Transl Res. 2017;9:611-619 pubmed
  45. Wang X, Xia Q, Ni H, Ye S, Li R, Wang X, et al. SFPQ/PSF-TFE3 renal cell carcinoma: a clinicopathologic study emphasizing extended morphology and reviewing the differences between SFPQ-TFE3 RCC and the corresponding mesenchymal neoplasm despite an identical gene fusion. Hum Pathol. 2017;63:190-200 pubmed publisher
  46. Bi Y, Shen W, Min M, Liu Y. MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma. Int J Mol Med. 2017;39:900-906 pubmed publisher
  47. Wu Y, Wang Y, Lin Y, Liu Y, Wang Y, Jia J, et al. Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation. Nat Commun. 2017;8:14228 pubmed publisher
  48. Carey S, MARTIN K, Reinhart King C. Three-dimensional collagen matrix induces a mechanosensitive invasive epithelial phenotype. Sci Rep. 2017;7:42088 pubmed publisher
  49. Jiu Y, Peranen J, Schaible N, Cheng F, Eriksson J, Krishnan R, et al. Vimentin intermediate filaments control actin stress fiber assembly through GEF-H1 and RhoA. J Cell Sci. 2017;130:892-902 pubmed publisher
  50. Beigi F, Patel M, Morales Garza M, Winebrenner C, Gobin A, Chau E, et al. Optimized method for isolating highly purified and functional porcine aortic endothelial and smooth muscle cells. J Cell Physiol. 2017;232:3139-3145 pubmed publisher
  51. Bordeleau F, Mason B, Lollis E, Mazzola M, Zanotelli M, Somasegar S, et al. Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci U S A. 2017;114:492-497 pubmed publisher
  52. Kusumoto H, Shintani Y, Kanzaki R, Kawamura T, Funaki S, Minami M, et al. Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma. Cancer Sci. 2017;108:528-535 pubmed publisher
  53. Yu J, Lei R, Zhuang X, Li X, Li G, Lev S, et al. MicroRNA-182 targets SMAD7 to potentiate TGF?-induced epithelial-mesenchymal transition and metastasis of cancer cells. Nat Commun. 2016;7:13884 pubmed publisher
  54. Han X, Fang Z, Wang H, Jiao R, Zhou J, Fang N. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494. Biochem Biophys Res Commun. 2016;480:675-681 pubmed publisher
  55. Xia Q, Wang Z, Chen N, Gan H, Teng X, Shi S, et al. Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement. Mod Pathol. 2017;30:416-426 pubmed publisher
  56. Tiwari A, Copeland C, Han B, Hanson C, Raghunathan K, Kenworthy A. Caveolin-1 is an aggresome-inducing protein. Sci Rep. 2016;6:38681 pubmed publisher
  57. Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
  58. Takai K, Le A, Weaver V, Werb Z. Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget. 2016;7:82889-82901 pubmed publisher
  59. Hofmann K, Lamberz C, Piotrowitz K, Offermann N, But D, Scheller A, et al. Tanycytes and a differential fatty acid metabolism in the hypothalamus. Glia. 2017;65:231-249 pubmed publisher
  60. Wizeman J, Nicholas A, Ishigami A, Mohan R. Citrullination of glial intermediate filaments is an early response in retinal injury. Mol Vis. 2016;22:1137-1155 pubmed
  61. Tonyali S, Yazici S, Yeşilırmak A, Ergen A. The Ewing's Sarcoma Family of Tumors of Urinary Bladder: A Case Report and Review of the Literature. Balkan Med J. 2016;33:462-6 pubmed publisher
  62. Deskin B, Lasky J, Zhuang Y, Shan B. Requirement of HDAC6 for activation of Notch1 by TGF-?1. Sci Rep. 2016;6:31086 pubmed publisher
  63. Iacovides D, Rizki G, Lapathitis G, Strati K. Direct conversion of mouse embryonic fibroblasts into functional keratinocytes through transient expression of pluripotency-related genes. Stem Cell Res Ther. 2016;7:98 pubmed publisher
  64. Jiang S, Chen G, Feng L, Jiang Z, Yu M, Bao J, et al. Disruption of kif3a results in defective osteoblastic differentiation in dental mesenchymal stem/precursor cells via the Wnt signaling pathway. Mol Med Rep. 2016;14:1891-900 pubmed publisher
  65. He Z, Forest F, Gain P, Rageade D, Bernard A, Acquart S, et al. 3D map of the human corneal endothelial cell. Sci Rep. 2016;6:29047 pubmed publisher
  66. Bai H, Wang M, Foster T, Hu H, He H, Hashimoto T, et al. Pericardial patch venoplasty heals via attraction of venous progenitor cells. Physiol Rep. 2016;4: pubmed publisher
  67. Zhang J, Sun D, Fu Q, Cao Q, Zhang H, Zhang K. Bone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment. Oncol Lett. 2016;12:644-650 pubmed
  68. Cui L, Wang Y, Yu R, Li B, Xie S, Gao Y, et al. Jia-Shen decoction-medicated serum inhibits angiotensin-II induced cardiac fibroblast proliferation via the TGF-?1/Smad signaling pathway. Mol Med Rep. 2016;14:1610-6 pubmed publisher
  69. Mokhtari S, Colletti E, Atala A, Zanjani E, Porada C, Almeida Porada G. Boosting Hematopoietic Engraftment after in Utero Transplantation through Vascular Niche Manipulation. Stem Cell Reports. 2016;6:957-969 pubmed publisher
  70. Li Q, Sodroski C, Lowey B, Schweitzer C, Cha H, Zhang F, et al. Hepatitis C virus depends on E-cadherin as an entry factor and regulates its expression in epithelial-to-mesenchymal transition. Proc Natl Acad Sci U S A. 2016;113:7620-5 pubmed publisher
  71. Kizuka Y, Nakano M, Miura Y, Taniguchi N. Epigenetic regulation of neural N-glycomics. Proteomics. 2016;16:2854-2863 pubmed publisher
  72. Lin S, Gou G, Hsia C, Ho C, Huang K, Wu Y, et al. Simulated Microgravity Disrupts Cytoskeleton Organization and Increases Apoptosis of Rat Neural Crest Stem Cells Via Upregulating CXCR4 Expression and RhoA-ROCK1-p38 MAPK-p53 Signaling. Stem Cells Dev. 2016;25:1172-93 pubmed publisher
  73. Kuang J, Li L, Guo L, Su Y, Wang Y, Xu Y, et al. RNF8 promotes epithelial-mesenchymal transition of breast cancer cells. J Exp Clin Cancer Res. 2016;35:88 pubmed publisher
  74. Farrugia A, Calvo F. Cdc42 regulates Cdc42EP3 function in cancer-associated fibroblasts. Small Gtpases. 2017;8:49-57 pubmed publisher
  75. Fu Q, Huang Y, Wang Z, Chen F, Huang D, Lu Y, et al. Proteome Profile and Quantitative Proteomic Analysis of Buffalo (Bubalusbubalis) Follicular Fluid during Follicle Development. Int J Mol Sci. 2016;17: pubmed publisher
  76. Roulois D, Deshayes S, Guilly M, Nader J, Liddell C, Robard M, et al. Characterization of preneoplastic and neoplastic rat mesothelial cell lines: the involvement of TETs, DNMTs, and 5-hydroxymethylcytosine. Oncotarget. 2016;7:34664-87 pubmed publisher
  77. Nakamura R, Koshiba Takeuchi K, Tsuchiya M, Kojima M, Miyazawa A, Ito K, et al. Expression analysis of Baf60c during heart regeneration in axolotls and neonatal mice. Dev Growth Differ. 2016;58:367-82 pubmed publisher
  78. Ren M, Du C, Herrero Acero E, Tang Schomer M, Ozkucur N. A biofidelic 3D culture model to study the development of brain cellular systems. Sci Rep. 2016;6:24953 pubmed publisher
  79. Ufimtseva E. Differences between Mycobacterium-Host Cell Relationships in Latent Tuberculous Infection of Mice Ex Vivo and Mycobacterial Infection of Mouse Cells In Vitro. J Immunol Res. 2016;2016:4325646 pubmed publisher
  80. Fuente Martín E, García Cáceres C, Argente Arizón P, Diaz F, Granado M, Freire Regatillo A, et al. Ghrelin Regulates Glucose and Glutamate Transporters in Hypothalamic Astrocytes. Sci Rep. 2016;6:23673 pubmed publisher
  81. Wu J, Ivanov A, Fisher P, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. elife. 2016;5: pubmed publisher
  82. Salzman D, Nakamura K, Nallur S, Dookwah M, Metheetrairut C, Slack F, et al. miR-34 activity is modulated through 5'-end phosphorylation in response to DNA damage. Nat Commun. 2016;7:10954 pubmed publisher
  83. Yin S, Fan Y, Zhang H, Zhao Z, Hao Y, Li J, et al. Differential TGF? pathway targeting by miR-122 in humans and mice affects liver cancer metastasis. Nat Commun. 2016;7:11012 pubmed publisher
  84. Thakur A, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, et al. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma. Cell Death Differ. 2016;23:1358-70 pubmed publisher
  85. Collazos Castro J, García Rama C, Alves Sampaio A. Glial progenitor cell migration promotes CNS axon growth on functionalized electroconducting microfibers. Acta Biomater. 2016;35:42-56 pubmed publisher
  86. Ke W, Chen C, Luo H, Tang J, Zhang Y, Gao W, et al. Histone Deacetylase 1 Regulates the Expression of Progesterone Receptor A During Human Parturition by Occupying the Progesterone Receptor A Promoter. Reprod Sci. 2016;23:955-64 pubmed publisher
  87. Chen Y, Statt S, Wu R, Chang H, Liao J, Wang C, et al. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep. 2016;6:18815 pubmed publisher
  88. Silva M, Matheus W, Garcia P, Stopiglia R, Billis A, Ferreira U, et al. Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells. Int Braz J Urol. 2015;41:849-58 pubmed publisher
  89. Smith K, Zhou B, Avdulov S, Benyumov A, Peterson M, Liu Y, et al. Transforming Growth Factor-β1 Induced Epithelial Mesenchymal Transition is blocked by a chemical antagonist of translation factor eIF4E. Sci Rep. 2015;5:18233 pubmed publisher
  90. Osorio L, Farfán N, Castellón E, Contreras H. SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells. Mol Med Rep. 2016;13:778-86 pubmed publisher
  91. Batchelder C, Martinez M, Tarantal A. Natural Scaffolds for Renal Differentiation of Human Embryonic Stem Cells for Kidney Tissue Engineering. PLoS ONE. 2015;10:e0143849 pubmed publisher
  92. Qi D, Kaur Gill N, Santiskulvong C, Sifuentes J, Dorigo O, Rao J, et al. Screening cell mechanotype by parallel microfiltration. Sci Rep. 2015;5:17595 pubmed publisher
  93. Eakins R, Walsh J, Randle L, Jenkins R, Schuppe Koistinen I, Rowe C, et al. Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome. Sci Rep. 2015;5:16423 pubmed publisher
  94. Shukla P, Vogl C, Wallner B, Rigler D, Müller M, Macho Maschler S. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells. BMC Genomics. 2015;16:944 pubmed publisher
  95. Jung M, Ryu Y, Kang G. Investigation of the origin of stromal and endothelial cells at the desmoplastic interface in xenograft tumor in mice. Pathol Res Pract. 2015;211:925-30 pubmed publisher
  96. Pai P, Rachagani S, Lakshmanan I, Macha M, Sheinin Y, Smith L, et al. The canonical Wnt pathway regulates the metastasis-promoting mucin MUC4 in pancreatic ductal adenocarcinoma. Mol Oncol. 2016;10:224-39 pubmed publisher
  97. Abou Kheir W, Eid A, El Merahbi R, Assaf R, Daoud G. A Unique Expression of Keratin 14 in a Subset of Trophoblast Cells. PLoS ONE. 2015;10:e0139939 pubmed publisher
  98. Santi A, Caselli A, Ranaldi F, Paoli P, Mugnaioni C, Michelucci E, et al. Cancer associated fibroblasts transfer lipids and proteins to cancer cells through cargo vesicles supporting tumor growth. Biochim Biophys Acta. 2015;1853:3211-23 pubmed publisher
  99. Forbes M, Thornhill B, Galarreta C, Chevalier R. A population of mitochondrion-rich cells in the pars recta of mouse kidney. Cell Tissue Res. 2016;363:791-803 pubmed publisher
  100. Maris P, Blomme A, Palacios A, Costanza B, Bellahcène A, Bianchi E, et al. Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer. PLoS Med. 2015;12:e1001871 pubmed publisher
  101. Garwood C, Ratcliffe L, Morgan S, Simpson J, Owens H, Vazquez Villaseñor I, et al. Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors. Mol Brain. 2015;8:51 pubmed publisher
  102. Stutz C, Reinz E, Honegger A, Bulkescher J, Schweizer J, Zanier K, et al. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides. PLoS ONE. 2015;10:e0132339 pubmed publisher
  103. Maggiorani D, Dissard R, Belloy M, Saulnier Blache J, Casemayou A, Ducassé L, et al. Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS ONE. 2015;10:e0131416 pubmed publisher
  104. Huo C, Chew G, Hill P, Huang D, Ingman W, Hodson L, et al. High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium. Breast Cancer Res. 2015;17:79 pubmed publisher
  105. Gago Fuentes R, Fernández Puente P, Megias D, Carpintero Fernández P, Mateos J, Acea B, et al. Proteomic Analysis of Connexin 43 Reveals Novel Interactors Related to Osteoarthritis. Mol Cell Proteomics. 2015;14:1831-45 pubmed publisher
  106. Ho F, Zhang W, Li Y, Chan B. Mechanoresponsive, omni-directional and local matrix-degrading actin protrusions in human mesenchymal stem cells microencapsulated in a 3D collagen matrix. Biomaterials. 2015;53:392-405 pubmed publisher
  107. Karbalaie K, Tanhaei S, Rabiei F, Kiani Esfahani A, Masoudi N, Nasr Esfahani M, et al. Stem cells from human exfoliated deciduous tooth exhibit stromal-derived inducing activity and lead to generation of neural crest cells from human embryonic stem cells. Cell J. 2015;17:37-48 pubmed
  108. Maity G, De A, Das A, Banerjee S, Sarkar S, Banerjee S. Aspirin blocks growth of breast tumor cells and tumor-initiating cells and induces reprogramming factors of mesenchymal to epithelial transition. Lab Invest. 2015;95:702-17 pubmed publisher
  109. Lund K, Dembinski J, Solberg N, Urbanucci A, Mills I, Krauss S. Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment. PLoS ONE. 2015;10:e0123684 pubmed publisher
  110. Lee S, Koh Y, Roh H, Cha H, Kwon Y. Ovarian microcystic stromal tumor: A novel extracolonic tumor in familial adenomatous polyposis. Genes Chromosomes Cancer. 2015;54:353-60 pubmed publisher
  111. Chen X, Liu X, Lang H, Zhang S, Luo Y, Zhang J. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line. PLoS ONE. 2015;10:e0121319 pubmed publisher
  112. Kawada M, Inoue H, Ohba S, Yoshida J, Masuda T, Yamasaki M, et al. Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interaction. PLoS ONE. 2015;10:e0119415 pubmed publisher
  113. Ma W, Na M, Tang C, Wang H, Lin Z. Overexpression of N-myc downstream-regulated gene 1 inhibits human glioma proliferation and invasion via phosphoinositide 3-kinase/AKT pathways. Mol Med Rep. 2015;12:1050-8 pubmed publisher
  114. Chang A, Liu Y, Ayyanathan K, Benner C, Jiang Y, Prokop J, et al. An evolutionarily conserved DNA architecture determines target specificity of the TWIST family bHLH transcription factors. Genes Dev. 2015;29:603-16 pubmed publisher
  115. Lin Y, Yang Z, Xu A, Dong P, Huang Y, Liu H, et al. PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway. Sci Rep. 2015;5:8997 pubmed publisher
  116. Liu M, Flanagan T, Lu C, French A, Argyle D, Corcoran B. Culture and characterisation of canine mitral valve interstitial and endothelial cells. Vet J. 2015;204:32-9 pubmed publisher
  117. Afzal M, Strande J. Generation of induced pluripotent stem cells from muscular dystrophy patients: efficient integration-free reprogramming of urine derived cells. J Vis Exp. 2015;:52032 pubmed publisher
  118. Wong E, Wong S, Chan C, Lam E, Ho L, Lau C, et al. TP53-induced glycolysis and apoptosis regulator promotes proliferation and invasiveness of nasopharyngeal carcinoma cells. Oncol Lett. 2015;9:569-574 pubmed
  119. Tange S, Oktyabri D, Terashima M, Ishimura A, Suzuki T. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines. PLoS ONE. 2014;9:e115684 pubmed publisher
  120. Yao P, Kang D, Wang X, Lin R, Ye Z. Cell-density-dependent manifestation of partial characteristics for neuronal precursors in a newly established human gliosarcoma cell line. In Vitro Cell Dev Biol Anim. 2015;51:345-52 pubmed publisher
  121. Park S, Bae H, Park J. Osteogenic differentiation and gene expression profile of human dental follicle cells induced by human dental pulp cells. J Mol Histol. 2015;46:93-106 pubmed publisher
  122. Liu D, Yovchev M, Zhang J, Alfieri A, Tchaikovskaya T, Laconi E, et al. Identification and characterization of mesenchymal-epithelial progenitor-like cells in normal and injured rat liver. Am J Pathol. 2015;185:110-28 pubmed publisher
  123. Johnson Kerner B, Ahmad F, Diaz A, Greene J, Gray S, Samulski R, et al. Intermediate filament protein accumulation in motor neurons derived from giant axonal neuropathy iPSCs rescued by restoration of gigaxonin. Hum Mol Genet. 2015;24:1420-31 pubmed publisher
  124. Milara J, Peiró T, Serrano A, Artigues E, Aparicio J, Tenor H, et al. Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro. COPD. 2015;12:320-31 pubmed publisher
  125. Li L, Fan X, Xia Q, Rao Q, Liu B, Yu B, et al. Concurrent loss of INI1, PBRM1, and BRM expression in epithelioid sarcoma: implications for the cocontributions of multiple SWI/SNF complex members to pathogenesis. Hum Pathol. 2014;45:2247-54 pubmed publisher
  126. Costache M, Pătraşcu O, Dumitru A, Costache D, Voinea L, Simionescu O, et al. Histopathological findings concerning ocular melanomas. Rom J Morphol Embryol. 2014;55:649-53 pubmed
  127. García E, Machesky L, Jones G, Antón I. WIP is necessary for matrix invasion by breast cancer cells. Eur J Cell Biol. 2014;93:413-23 pubmed publisher
  128. Foret M, Sandstrom R, Rhodes C, Wang Y, Berger M, Lin C. Molecular targets of chromatin repressive mark H3K9me3 in primate progenitor cells within adult neurogenic niches. Front Genet. 2014;5:252 pubmed publisher
  129. Krivega M, Geens M, Van de Velde H. CAR expression in human embryos and hESC illustrates its role in pluripotency and tight junctions. Reproduction. 2014;148:531-44 pubmed publisher
  130. Guan H, Tan J, Zhang F, Gao L, Bai L, Qi D, et al. Myofibroblasts from salivary gland adenoid cystic carcinomas promote cancer invasion by expressing MMP2 and CXCL12. Histopathology. 2015;66:781-90 pubmed publisher
  131. McLane J, Rivet C, Gilbert R, Ligon L. A biomaterial model of tumor stromal microenvironment promotes mesenchymal morphology but not epithelial to mesenchymal transition in epithelial cells. Acta Biomater. 2014;10:4811-4821 pubmed publisher
  132. Yuan S, Guo Y, Zhou X, Shen W, Chen H. PDGFR-? (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo. Int J Clin Exp Pathol. 2014;7:2861-70 pubmed
  133. Fenton S, Hutchens K, Denning M. Targeting Fyn in Ras-transformed cells induces F-actin to promote adherens junction-mediated cell-cell adhesion. Mol Carcinog. 2015;54:1181-93 pubmed publisher
  134. van Neerven S, Krings L, Haastert Talini K, Vogt M, Tolba R, Brook G, et al. Human Schwann cells seeded on a novel collagen-based microstructured nerve guide survive, proliferate, and modify neurite outgrowth. Biomed Res Int. 2014;2014:493823 pubmed publisher
  135. Yi X, Li X, Zhou Y, Ren S, Wan W, Feng G, et al. Hepatocyte growth factor regulates the TGF-?1-induced proliferation, differentiation and secretory function of cardiac fibroblasts. Int J Mol Med. 2014;34:381-90 pubmed publisher
  136. Muchkaeva I, Dashinimaev E, Artyuhov A, Myagkova E, Vorotelyak E, Yegorov Y, et al. Generation of iPS Cells from Human Hair Follice Dermal Papilla Cells. Acta Naturae. 2014;6:45-53 pubmed
  137. Kerdivel G, Boudot A, Habauzit D, Percevault F, Demay F, Pakdel F, et al. Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines. Mol Cell Endocrinol. 2014;390:34-44 pubmed publisher
  138. Milara J, Peiró T, Serrano A, Guijarro R, Zaragozá C, Tenor H, et al. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD. Pulm Pharmacol Ther. 2014;28:138-48 pubmed publisher
  139. Hesami P, Holzapfel B, Taubenberger A, Roudier M, Fazli L, Sieh S, et al. A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone. Clin Exp Metastasis. 2014;31:435-46 pubmed publisher
  140. Bohonowych J, Hance M, Nolan K, DEFEE M, Parsons C, Isaacs J. Extracellular Hsp90 mediates an NF-?B dependent inflammatory stromal program: implications for the prostate tumor microenvironment. Prostate. 2014;74:395-407 pubmed publisher
  141. Yu Y, Xiao C, Tan L, Wang Q, Li X, Feng Y. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-? signalling. Br J Cancer. 2014;110:724-32 pubmed publisher
  142. Chen Y, Pan H, Tseng H, Chu H, Hung Y, Yen Y, et al. Differentiated epithelial- and mesenchymal-like phenotypes in subcutaneous mouse xenografts using diffusion weighted-magnetic resonance imaging. Int J Mol Sci. 2013;14:21943-59 pubmed publisher
  143. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  144. Xu Y, Xu Y, Liao L, Zhou N, Theissen S, Liao X, et al. Inducible knockout of Twist1 in young and adult mice prolongs hair growth cycle and has mild effects on general health, supporting Twist1 as a preferential cancer target. Am J Pathol. 2013;183:1281-1292 pubmed publisher
  145. Olsen J, Oyan A, Rostad K, Hellem M, Liu J, Li L, et al. p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLoS ONE. 2013;8:e62547 pubmed publisher
  146. Yang G, Li J, Jin H, Ding H. Is mammary not otherwise specified-type sarcoma with CD10 expression a distinct entity? A rare case report with immunohistochemical and ultrastructural study. Diagn Pathol. 2013;8:14 pubmed publisher
  147. Rodriguez A, Allegrucci C, Alberio R. Modulation of pluripotency in the porcine embryo and iPS cells. PLoS ONE. 2012;7:e49079 pubmed publisher
  148. Ezponda T, Popovic R, Shah M, Martinez Garcia E, Zheng Y, Min D, et al. The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene. 2013;32:2882-90 pubmed publisher
  149. Stoyianni A, Goussia A, Pentheroudakis G, Siozopoulou V, Ioachim E, Krikelis D, et al. Immunohistochemical study of the epithelial-mesenchymal transition phenotype in cancer of unknown primary: incidence, correlations and prognostic utility. Anticancer Res. 2012;32:1273-81 pubmed
  150. Yuan S, Chen R, Shen W, Chen H, Zhou X. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region. Pediatr Dev Pathol. 2012;15:5-12 pubmed publisher
  151. Gil da Costa R, Santos M, Amorim I, Lopes C, Pereira P, Faustino A. An immunohistochemical study of feline endometrial adenocarcinoma. J Comp Pathol. 2009;140:254-9 pubmed publisher
  152. Fu X, Fang L, Li H, Li X, Cheng B, Sheng Z. Adipose tissue extract enhances skin wound healing. Wound Repair Regen. 2007;15:540-8 pubmed
  153. Hartwell K, Muir B, Reinhardt F, Carpenter A, Sgroi D, Weinberg R. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A. 2006;103:18969-74 pubmed
  154. Hertig A, Verine J, Mougenot B, Jouanneau C, Ouali N, Sebe P, et al. Risk factors for early epithelial to mesenchymal transition in renal grafts. Am J Transplant. 2006;6:2937-46 pubmed
  155. Baravalle C, Salvetti N, Mira G, Pezzone N, Ortega H. Microscopic characterization of follicular structures in letrozole-induced polycystic ovarian syndrome in the rat. Arch Med Res. 2006;37:830-9 pubmed
  156. Baravalle C, Salvetti N, Mira G, Lorente J, Ortega H. The role of ACTH in the pathogenesis of polycystic ovarian syndrome in rats: hormonal profiles and ovarian morphology. Physiol Res. 2007;56:67-78 pubmed
  157. Guarino M, Ballabio G, Rubino B, Nebuloni M, Tosoni A. Soft tissue sacrococcygeal chordoma with intracytoplasmic filamentous inclusions. Pathol Res Pract. 2005;201:699-704 pubmed
  158. Lu S, Yu G, Zhu Y, Archer M. Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation. Int J Cancer. 2005;116:847-52 pubmed